| Reviews |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Accuracy of telomerase in estimating breast cancer risk: A systematic review and meta-analysis
12 September 2011
Abstract: Objective: To determine the accuracy of telomerase activity in predicting a higher risk for breast cancer. Study design: A quantitative systematic review was performed. Studies that detected...
|
Erik P. Winnikow,
Lidia R. Medeiros,
Maria I. Edelweiss,
Daniela D. Rosa,
Marcia Edelweiss,
Priscyla W. Simões,
Fábio R. Silva,
Bruno R. Silva,
Maria I. Rosa
et al.
|
1-7
|
|
|
|
Bone health management in patients with breast cancer: Current standards and emerging strategies
28 September 2011
Abstract: In women who develop bone metastases from breast cancer (BC), interactions between tumor cells and osteoclasts within the bone lead to localized bone destruction and increase the risk of ske...
|
Matti S. Aapro,
Robert E. Coleman
|
8-19
|
|
|
|
Triple negative breast cancer: Proposals for a pragmatic definition and implications for patient management and trial design
10 October 2011
Abstract: In trials in triple negative breast cancer (TNBC), oestrogen and progesterone receptor negativity should be defined as < 1% positive cells. Negativity is a ratio of <2 between Her2 gen...
|
W. Eiermann,
J. Bergh,
F. Cardoso,
P. Conte,
J. Crown,
N.J. Curtin,
J. Gligorov,
B. Gusterson,
H. Joensuu,
B.K. Linderholm,
M. Martin,
F. Penault-Llorca,
B.C. Pestalozzi,
E. Razis,
C. Sotiriou,
S. Tjulandin,
G. Viale
et al.
|
20-26
|
|
| Original Articles |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial
22 August 2011
Abstract: The eLEcTRA trial compared efficacy and safety of letrozole combined with trastuzumab to letrozole alone in patients with HER2 and hormone receptor (HR) positive metastatic breast cancer (MB...
|
J. Huober,
P.A. Fasching,
M. Barsoum,
L. Petruzelka,
D. Wallwiener,
C. Thomssen,
T. Reimer,
S. Paepke,
H.A. Azim,
V. Ragosch,
E. Kubista,
A.K. Baumgärtner,
M.W. Beckmann,
C. May,
I. Nimmrich,
N. Harbeck
et al.
|
27-33
|
|
|
|
Comparative study of spatial localization of HER-2 and CEP17 signals and of HER-2/CEP17 ratios, in “thin” and “thick” tissue sections
22 August 2011
Abstract: One presumed drawback of performing fluorescence in situ hybridization on routine tissue sections for HER-2 status evaluation in breast carcinomas is nuclear truncation. Therefore, HER-2/CEP...
|
E. Kouvaras,
C.N. Papandreou,
D.D. Daliani,
A. Athanasiadis,
G.K. Koukoulis
et al.
|
34-39
|
|
|
|
Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer
22 August 2011
Abstract: Background: Some studies have shown that high body mass index (BMI) is associated with inferior outcome after adjuvant therapy with anastrozole in breast cancer patients. We aimed to investi...
|
Masahiro Takada,
Shigehira Saji,
Norikazu Masuda,
Katsumasa Kuroi,
Nobuaki Sato,
Hiroyuki Takei,
Yutaka Yamamoto,
Shinji Ohno,
Hiroko Yamashita,
Kazufumi Hisamatsu,
Kenjiro Aogi,
Hiroji Iwata,
Takayuki Ueno,
Hironobu Sasano,
Masakazu Toi
et al.
|
40-45
|
|
|
|
Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: A randomized trial
24 August 2011
Abstract: Persistent pain after breast cancer treatment (PPBCT) affects between 25 and 60% of patients depending on surgical and adjuvant treatment. External breast radiotherapy (EBRT) has been shown ...
|
Kenneth Geving Andersen,
Rune Gärtner,
Niels Kroman,
Henrik Flyger,
Henrik Kehlet
et al.
|
46-49
|
|
|
|
Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry
25 August 2011
Abstract: To investigate the significance of immunohistochemical molecular subtyping, we evaluated outcomes of subtypes based on estrogen receptor (ER), progesterone receptor (PR), human epidermal gro...
|
Seho Park,
Ja Seung Koo,
Min Suk Kim,
Hyung Seok Park,
Jun Sang Lee,
Jong Seok Lee,
Seung Il Kim,
Byeong-Woo Park
et al.
|
50-57
|
|
|
|
Re-evaluating the role of axillary lymph node dissection in screen-detected breast cancer patients
07 September 2011
Abstract: Introduction: The American College of Surgeons Oncology Group (ACOSOG), Z0011 trial, demonstrated that there was no therapeutic benefit from completion lymphadenectomy in early stage breast ...
|
M. Barry,
M.R. Kell
|
58-60
|
|
|
|
Objective assessment of aesthetic outcome after breast conserving therapy: Subjective third party panel rating and objective BCCT.core software evaluation
18 August 2011
Abstract: We analysed intra- and inter-rater agreement of subjective third party assessment and agreement with a semi-automated objective software evaluation tool (BCCT.core). We presented standardize...
|
Joerg Heil,
Anne Carolus,
Julia Dahlkamp,
Michael Golatta,
Christoph Domschke,
Florian Schuetz,
Maria Blumenstein,
Geraldine Rauch,
Christof Sohn
et al.
|
61-65
|
|
|
|
Imaging sensitivity of dedicated positron emission mammography in relation to tumor size
29 August 2011
Abstract: Positron emission mammography (PEM) has been reported to have higher sensitivity than whole-body positron emission tomography (PET)due to higher spatial resolution. However, no direct eviden...
|
Jae Seon Eo,
In Kook Chun,
Jin Chul Paeng,
Keon Wook Kang,
Sang Mi Lee,
Wonshik Han,
Dong-Young Noh,
June-Key Chung,
Dong Soo Lee
et al.
|
66-71
|
|
|
|
A pilot study to examine the experiences and attitudes of women with breast cancer towards one versus two-step axillary surgery
29 August 2011
Abstract: Purpose: To elicit the views, experiences and preferences of women with clinically node negative breast cancer towards intra-operative sentinel lymph node biopsy (SLNB) analysis. Methods: Fo...
|
V. Jenkins,
H. Harder,
M. Babar,
S. Merry,
S. Newbury,
M. Kissin,
C. Zammit
et al.
|
72-76
|
|
|
|
The decline in breast cancer mortality in Europe: An update (to 2009)
09 September 2011
Abstract: We updated trends in breast cancer mortality in Europe up to the late 2000’s. In the EU, age-adjusted (world standard population) breast cancer mortality rates declined by 6.9% between 2002 ...
|
Cristina Bosetti,
Paola Bertuccio,
Fabio Levi,
Liliane Chatenoud,
Eva Negri,
Carlo La Vecchia
et al.
|
77-82
|
|
|
|
Anxiety after an abnormal screening mammogram is a serious problem
19 September 2011
Abstract: Purpose: The aim of this study was to analyze the possible negative psychological consequences of a false positive screening mammogram (FPSM). We compared anxiety evoked by first (FSM) versu...
|
Claudia M.G. Keyzer-Dekker,
Jolanda De Vries,
Lotje van Esch,
Miranda F. Ernst,
Grard A.P. Nieuwenhuijzen,
Jan A. Roukema,
Alida F.W. van der Steeg
et al.
|
83-88
|
|
|
|
Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: A pooled subset analysis of two phase III studies
22 September 2011
Abstract: Background: Metastatic breast cancer (MBC) patients with rapid disease relapse after neo/adjuvant chemotherapy including anthracyclines and taxanes have limited treatment options and their e...
|
Jacek Jassem,
Luis Fein,
Mark Karwal,
Mario Campone,
Ronald Peck,
Valerie Poulart,
Linda Vahdat
et al.
|
89-94
|
|
|
|
Bone health in a prospective cohort of postmenopausal women receiving aromatase inhibitors for early breast cancer
19 September 2011
Abstract: Objective: Baseline bone health in postmenopausal women is poorly characterized in prospective series of early breast cancer (EBC) patients candidates to aromatase inhibitor (AI) therapy. Ou...
|
Sònia Servitja,
Xavier Nogués,
Daniel Prieto-Alhambra,
María Martínez-García,
Laia Garrigós,
María Jesús Peña,
Marta de Ramon,
Adolfo Díez-Pérez,
Joan Albanell,
Ignasi Tusquets
et al.
|
95-101
|
|
| Short Communications |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Breast implant related Anaplastic Large Cell Lymphoma presenting as late onset peri-implant effusion
16 August 2011
Abstract: In the past 10 years there has been a number of case reports of lymphoma associated with implants. In January 2011 the US FDA (United States Food and Drug Administration) produced a review o...
|
Trevor J. Smith,
Reena Ramsaroop
|
102-104
|
|
|
|
Breast reconstruction: A quality measure for breast cancer care?
05 September 2011
Abstract: Parallel to its life-threatening nature, breast cancer can affect physical integrity, having a psychosocial impact on patients. Determining the optimal proportion of patients who should unde...
|
C.A. Garcia-Etienne,
D. Forcellini,
A. Sagona,
F. Caviggioli,
E. Barbieri,
G. Cornegliani,
S. Giannasi,
C. Tinterri
et al.
|
105-106
|
|
| Correspondence |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Can all beta blockers improve the breast cancer survival?
17 October 2011
Recent studies have showed the importance of neuroendocrine regulation of breast cancer progression. Preclinical and epidemiological studies have designated that sympathetic nervous system and adrener...
|
Mehmet Ali Nahit Sendur,
Sercan Aksoy,
Sebnem Yaman,
Zafer Arik,
Kadri Altundag
et al.
|
107-108
|
|
|
|
Men’s experiences of gynaecomastia and corrective surgery: A qualitative report
09 November 2011
An increasing number of men are reporting dissatisfaction with some aspect of their body. It is therefore unsurprising that the number of men undergoing breast reduction surgery in the UK increased by...
|
Sinead NiMhurchadha,
Jennifer Hughes,
Charles Nduka,
Diana Harcourt
|
108
|
|
|
|
Letter in response to Macdonald C, Nakhdjevani A, Shah A. The “Swiss-Roll” flap: A modified C–V flap for nipple reconstruction. The Breast 20 (2011) 475–477
14 December 2011
We write in response to the recent article by Macdonald et al. advocating a method of local flap nipple reconstruction .
|
Edward Matthews,
Foiz Ahmed,
John Breeze,
Simon Heppell
|
109
|
|
